Diverticular disease of the intestine
Conditions
Brief summary
Therapeutic failure rate (early, within ≤48 hours, and at one month) for both treatments (with and without antibiotics).
Detailed description
Results in terms of recurrence (number, type, and time to onset)., Time (days) until clinical recovery and return to daily social and work life., Risk factors for the development of diverticulitis and prognostic factors predictive of therapeutic failure and unfavorable progression to complicated acute diverticulitis, in general and according to treatment group, Quality of life and level of satisfaction with the care received in both groups
Interventions
DRUGamoxicilina/ácido clavulánico cinfa 875 mg/125 mg comprimidos recubiertos con película EFG
DRUGMEIACT 200 mg comprimidos recubiertos con película
DRUGcefuroxima cinfa 250 mg comprimidos recubiertos con película EFG
DRUGciprofloxacino cinfa 500 mg comprimidos recubiertos EFG
Sponsors
Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Therapeutic failure rate (early, within ≤48 hours, and at one month) for both treatments (with and without antibiotics). | — |
Secondary
| Measure | Time frame |
|---|---|
| Results in terms of recurrence (number, type, and time to onset)., Time (days) until clinical recovery and return to daily social and work life., Risk factors for the development of diverticulitis and prognostic factors predictive of therapeutic failure and unfavorable progression to complicated acute diverticulitis, in general and according to treatment group, Quality of life and level of satisfaction with the care received in both groups | — |
Outcome results
None listed